OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION

Generic: OLOPATADINE HYDROCHLORIDE OPHTHALMIC

Gland Pharma LimitedManufacturer
OPHTHALMICRoute
OLOPATADINE HYDROCHLORIDEActive Substance
2019-08-02Original Approval

OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION is FDA application ANDA209619, sponsored by GLAND. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
TREATMENT FAILURE
1,933 reports
2
DRUG INEFFECTIVE
264 reports
3
HEADACHE
117 reports
4
NAUSEA
117 reports
5
DIARRHOEA
114 reports
6
FATIGUE
104 reports
7
PYREXIA
104 reports
8
PNEUMONIA
103 reports
9
MALAISE
99 reports
10
RASH
97 reports